Connie I. Lord

644 total citations
14 papers, 524 citations indexed

About

Connie I. Lord is a scholar working on Molecular Biology, Immunology and Microbiology. According to data from OpenAlex, Connie I. Lord has authored 14 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Immunology and 5 papers in Microbiology. Recurrent topics in Connie I. Lord's work include Immune Response and Inflammation (7 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers) and Antimicrobial Peptides and Activities (5 papers). Connie I. Lord is often cited by papers focused on Immune Response and Inflammation (7 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers) and Antimicrobial Peptides and Activities (5 papers). Connie I. Lord collaborates with scholars based in United States and Netherlands. Connie I. Lord's co-authors include Algirdas J. Jesaitis, J. Emmett Duffy, Michael J. Franklin, Zbigniew Lewandowski, Deborah L. Berglund, Maiko Sasaki, Haluk Beyenal, Jeannie M. Gripentrog, R. M. Taylor and James B. Burritt and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Connie I. Lord

14 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Connie I. Lord United States 11 335 211 71 69 56 14 524
Klaus‐Dieter Hungerer Germany 8 200 0.6× 191 0.9× 46 0.6× 44 0.6× 46 0.8× 11 479
Cecilia A. Hinojosa United States 11 273 0.8× 162 0.8× 100 1.4× 46 0.7× 70 1.3× 16 661
Sarah A. Tursi United States 12 364 1.1× 110 0.5× 47 0.7× 104 1.5× 6 0.1× 15 563
Catherine L. Hall United Kingdom 7 157 0.5× 233 1.1× 110 1.5× 47 0.7× 24 0.4× 11 496
O Bajolet-Laudinat France 8 281 0.8× 57 0.3× 75 1.1× 30 0.4× 190 3.4× 8 502
Yash R. Patankar United States 7 200 0.6× 103 0.5× 31 0.4× 23 0.3× 69 1.2× 7 348
Michael A. Gurney United States 12 190 0.6× 91 0.4× 111 1.6× 38 0.6× 24 0.4× 17 647
Valerie Sloane United States 6 222 0.7× 192 0.9× 19 0.3× 23 0.3× 76 1.4× 6 493
Per Jensen Denmark 9 380 1.1× 53 0.3× 38 0.5× 12 0.2× 170 3.0× 10 557
H. Kumada Japan 10 141 0.4× 246 1.2× 58 0.8× 35 0.5× 15 0.3× 15 508

Countries citing papers authored by Connie I. Lord

Since Specialization
Citations

This map shows the geographic impact of Connie I. Lord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Connie I. Lord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Connie I. Lord more than expected).

Fields of papers citing papers by Connie I. Lord

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Connie I. Lord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Connie I. Lord. The network helps show where Connie I. Lord may publish in the future.

Co-authorship network of co-authors of Connie I. Lord

This figure shows the co-authorship network connecting the top 25 collaborators of Connie I. Lord. A scholar is included among the top collaborators of Connie I. Lord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Connie I. Lord. Connie I. Lord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Miettinen, Heini M., Jeannie M. Gripentrog, Connie I. Lord, & Jon O. Nagy. (2018). CD177-mediated nanoparticle targeting of human and mouse neutrophils. PLoS ONE. 13(7). e0200444–e0200444. 33 indexed citations
2.
Leoni, Giovanna, Jeannie M. Gripentrog, Connie I. Lord, et al.. (2014). Human neutrophil formyl peptide receptor phosphorylation and the mucosal inflammatory response. Journal of Leukocyte Biology. 97(1). 87–101. 19 indexed citations
3.
Maaty, Walid S., Connie I. Lord, Jeannie M. Gripentrog, et al.. (2013). Identification of C-terminal Phosphorylation Sites of N-Formyl Peptide Receptor-1 (FPR1) in Human Blood Neutrophils. Journal of Biological Chemistry. 288(38). 27042–27058. 14 indexed citations
4.
Taylor, R. M., Marcia H. Riesselman, Connie I. Lord, Jeannie M. Gripentrog, & Algirdas J. Jesaitis. (2012). Anionic lipid-induced conformational changes in human phagocyte flavocytochrome b precede assembly and activation of the NADPH oxidase complex. Archives of Biochemistry and Biophysics. 521(1-2). 24–31. 10 indexed citations
5.
Lord, Connie I., Jeannie M. Gripentrog, R. M. Taylor, et al.. (2007). Localization of hCAP-18 on the surface of chemoattractant-stimulated human granulocytes: analysis using two novel hCAP-18-specific monoclonal antibodies. Journal of Leukocyte Biology. 82(1). 161–172. 7 indexed citations
6.
Riesselman, Marcia H., Heini M. Miettinen, Jeannie M. Gripentrog, et al.. (2007). C-Terminal Tail Phosphorylation of N -Formyl Peptide Receptor: Differential Recognition of Two Neutrophil Chemoattractant Receptors by Monoclonal Antibodies NFPR1 and NFPR2. The Journal of Immunology. 179(4). 2520–2531. 13 indexed citations
7.
Lord, Connie I., Marcia H. Riesselman, Jeannie M. Gripentrog, et al.. (2007). Single-step immunoaffinity purification and functional reconstitution of human phagocyte flavocytochrome b. Journal of Immunological Methods. 329(1-2). 201–207. 12 indexed citations
8.
Taylor, R. M., Connie I. Lord, Marcia H. Riesselman, et al.. (2007). Characterization of Surface Structure and p47phox SH3 Domain-Mediated Conformational Changes for Human Neutrophil Flavocytochrome b. Biochemistry. 46(49). 14291–14304. 11 indexed citations
9.
Taylor, R. M., Walid S. Maaty, Connie I. Lord, et al.. (2006). Cloning, sequence analysis and confirmation of derived gene sequences for three epitope-mapped monoclonal antibodies against human phagocyte flavocytochrome b. Molecular Immunology. 44(4). 625–637. 5 indexed citations
10.
Taylor, R. M., Danas Baniulis, James B. Burritt, et al.. (2006). Analysis of Human Phagocyte Flavocytochrome b558 by Mass Spectrometry. Journal of Biological Chemistry. 281(48). 37045–37056. 19 indexed citations
11.
Taylor, R. M., James B. Burritt, Danas Baniulis, et al.. (2004). Site-Specific Inhibitors of NADPH Oxidase Activity and Structural Probes of Flavocytochrome b : Characterization of Six Monoclonal Antibodies to the p22 phox Subunit. The Journal of Immunology. 173(12). 7349–7357. 51 indexed citations
12.
Burritt, James B., Thomas R. Foubert, Danas Baniulis, et al.. (2003). Functional Epitope on Human Neutrophil Flavocytochrome b 558. The Journal of Immunology. 170(12). 6082–6089. 37 indexed citations
13.
Taylor, R. M., James B. Burritt, Thomas R. Foubert, et al.. (2003). Single-step immunoaffinity purification and characterization of dodecylmaltoside-solubilized human neutrophil flavocytochrome b. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1612(1). 65–75. 16 indexed citations
14.
Jesaitis, Algirdas J., Michael J. Franklin, Deborah L. Berglund, et al.. (2003). Compromised Host Defense on Pseudomonas aeruginosa Biofilms: Characterization of Neutrophil and Biofilm Interactions. The Journal of Immunology. 171(8). 4329–4339. 277 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026